News

Saama Data Analytics Platform Runs On Machine Learning

Senior VP of Clinical Innovations, Amit Gulwadi, was featured in an article from Clinical Research News on the different ways that the LSAC makes use of machine learning. “In the world of clinical development, information is stored in a multitude of places, from clinical trial management systems and electronic data capture systems to third-party labs…

Read More

Health Technology: The Merging Disciplines of Medicine and Innovation

Chief Strategy Officer, Sagar Anisingaraju, was quoted in a recent PharmaVOICE article discussing how to overcome the challenge of big data and AI’s relative “newness” within the pharma industry. “A clinical neural network would mean research sharing across thousands of studies conducted in different therapeutic areas by different companies,” Mr. Anisingaraju says. “This is one area where…

Read More

Saama Acquires Comprehend to Form Preeminent Clinical Analytics Platform Company

Transaction Creates Expanded Portfolio of Cloud-Based Capabilities to Advance Clinical Development CAMPBELL, CA and REDWOOD CITY, CA – (August 13, 2019) – Saama Technologies, Inc. (“Saama”) announced today that it has signed a definitive agreement to acquire Comprehend Systems, Inc. (“Comprehend”). This agreement combines Saama and Comprehend’s respective industry positions as leading clinical data analytics…

Read More

DIA 2019 PharmaVoice Editor’s Take

August 2, 2019 – Vice President of Sales, Joe Ehrline, talks about the opportunities and benefits that life-science companies can gain by effectively employing data analytics as part of a comprehensive strategy to accelerate drug development.

Read More

Saama Collaborates with Researchers to Assess Technology Adoption in Drug Development

Collaboration Continues Saama’s Commitment to Academic Alliances that Advance Clinical Operations CAMPBELL, CA – (July 9, 2019) – Saama Technologies, Inc. (“Saama”), a leading clinical data analytics company, today announced a collaboration with researchers at the Tufts Center for the Study of Drug Development (Tufts CSDD) at Tufts University School of Medicine to ascertain how…

Read More

Related Posts